Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-23-008738
Filing Date
2023-12-08
Accepted
2023-12-08 17:30:11
Documents
1
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3854
  Complete submission text file 0001683168-23-008738.txt   5385
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENETIC BIOSCIENCES, INC. 40 SPEEN STREET FRAMINGHAM MA 01701
Business Address
VINOGRADOV ALEXEY ANDREEVICH (Reporting) CIK: 0001784315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 231476443